6N79

Structure of the human JAK1 kinase domain with compound 20

6N79 の概要

• エントリーDOI: 10.2210/pdb6n79/pdb
• 分子名称: Tyrosine-protein kinase JAK1, N-{5-[5-chloro-2-(difluoromethoxy)phenyl]-1H-pyrazol-4-yl}pyrazolo[1,5-a]pyrimidine-3-carboxamide, GLYCEROL, ... (4 entities in total)
• 機能のキーワード: jak1, il13, il-13, jak2, jak3, tyk2, immune system
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 35243.45

構造登録者

Lupardus, P.J.,Brown, D. (登録日: 2018-11-27, 公開日: 2019-04-24, 最終更新日: 2019-05-15)

• 主引用文献: Zak, M.,Hanan, E.J.,Lupardus, P.,Brown, D.G.,Robinson, C.,Siu, M.,Lyssikatos, J.P.,Romero, F.A.,Zhao, G.,Kellar, T.,Mendonca, R.,Ray, N.C.,Goodacre, S.C.,Crackett, P.H.,McLean, N.,Hurley, C.A.,Yuen, P.W.,Cheng, Y.X.,Liu, X.,Liimatta, M.,Kohli, P.B.,Nonomiya, J.,Salmon, G.,Buckley, G.,Lloyd, J.,Gibbons, P.,Ghilardi, N.,Kenny, J.R.,Johnson, A.; Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling.; Bioorg.Med.Chem.Lett., 29:1522-1531, 2019; PubMed: 30981576; DOI: 10.1016/j.bmcl.2019.04.008

実験手法

X-RAY DIFFRACTION (2.27 Å)